GlassScriptPhysician profile
James S Mcintyre
NPI 1043446602
$600.07
in general payments reported to CMS, 2019-2025
11 companies · $292 in 2025
The $292 reported for 2025 was more than what 75% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.49 · 2021: $62.96 · 2022: $42.90 · 2023: $82.72 · 2024: $88.81 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $133.17 | 2025 | Sx-One Microknife |
| Sanofi-Aventis U.S. LLC | $78.84 | 2022-2024 | |
| Depuy Synthes Sales INC. | $78.21 | 2020-2024 | Monovisc, Orthovisc, Peak |
| Stryker Corporation | $61.94 | 2021-2024 | Mako |
| Orthofix Medical, INC. | $60.39 | 2023-2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $55.52 | 2025 | Juggerknotless Soft Anchor |
| Rgh Enterprises LLC | $37.61 | 2025 | |
| Ferring Pharmaceuticals INC. | $36.85 | 2021-2022 | |
| Pacira Therapeutics, INC. | $22.86 | 2021 | |
| Novo Nordisk INC | $19.67 | 2025 | Rybelsus, Ozempic |
| Solventum Corporation | $15.01 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.